Health system announces new plan to refund patients if expectations aren't met

Michael Walter | | Health Exec | Policy & Regulations

Have you ever had an unpleasant experience at a doctor’s office or hospital? Did you get your co-pay back?

The Pennsylvania-based Geisinger Health System has unveiled its ProvenExperience program, which offers refunds to patients who don’t have their expectations met while receiving care.

Geisinger Health System president and CEO David T. Feinberg, MD, announced the program on Nov. 11, at the 2015 Press Ganey Executive Leadership Conference in Orlando, Fla.

"The way I see it, if you go into Starbucks and you're not happy with your order, they don't sip your latte and argue that they made it correctly,” Feinberg said during his presentation. “They just take care of you on the spot. What matters to me is that every patient is satisfied with their treatment and so I started thinking, 'What is our guarantee? What is our refund?’”

Read the full story below:

Health system lauded for innovation now offering famous 'warranty' based on pat…

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
Advancing AI for vascular surgery will require a commitment to data integrity

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.